Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism DKK2 inhibitors(Dickkopf-related protein 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | China | 23 Mar 2020 |






